Making lung toxicity predictive, not reactive
This session highlighted where prediction fails today, the mechanistic gaps that limit current approaches, and how human NAMs can help close that gap. It…
Lorem ipsum dolor sit amet, consectetur adipiscing elit. Suspendisse quis nibh eget urna placerat dictum in ac mauris. Etiam pellentesque tristique pretium.
This session highlighted where prediction fails today, the mechanistic gaps that limit current approaches, and how human NAMs can help close that gap. It…
To deliver therapeutics effectively to the nasal and pulmonary regions, developers must address the physiological barriers in these tissues. This webinar covers how formulation…
In the first session of our Season 2 ImmuBYTES webinar series, Principal Scientist, Josephine Joel explores one of the biggest challenges in antibody-drug conjugate…
DateCategory Watching Time 21 Minutes https://immuone.com/wp-content/uploads/2025/07/ImmuONE.mp4 Get in touch Add a Comment Related Posts
In ImmuBYTES Session 3, “Looking Beyond Baseline Deviations for Lung and Immune Safety,” Prof. Victoria Hutter (CSO & Co-founder) highlighted how subtle changes in…
Immune cells are reshaping inhalation toxicology by offering deeper insights into respiratory and systemic effects of tested compounds. In the second ImmuBYTES webinar, ‘Immune…
A UK biotech start-up with a 3D human lung model that provides an alternative to animal testing has raised a further £600,000 from the…
Welcome to ImmuBYTES, a new series designed to deliver bite-sized insights into cutting-edge tools in cell-based research and toxicology to drive innovation and discovery.
In our recent ImmuBYTES webinar, we delved into the fascinating world of Cell Painting, a high-content imaging assay (HCIA) that transforms cellular morphology into…